Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2004

01-01-2004 | Originales

Análisis mutacional de los genes de la familiaTP53 en oligodendrogliomas

Authors: María Eva Alonso Fernández, María Josefa Bello González, Cinthia Aniñoso Carbonero, Dolores Arjona Mayor, Pilar González Gómez, Jesús Lomas Huertas, Isabel López Marín, José María de Campos Gutiérrez, Jesús Vaquero Crespo, Alberto Isla Guerrero, Manuel Gutiérrez Molina, José Luis Sarasa Corral, Juan Antonio Rey Herranz

Published in: Clinical and Translational Oncology | Issue 1/2004

Login to get access
Metadata
Title
Análisis mutacional de los genes de la familiaTP53 en oligodendrogliomas
Authors
María Eva Alonso Fernández
María Josefa Bello González
Cinthia Aniñoso Carbonero
Dolores Arjona Mayor
Pilar González Gómez
Jesús Lomas Huertas
Isabel López Marín
José María de Campos Gutiérrez
Jesús Vaquero Crespo
Alberto Isla Guerrero
Manuel Gutiérrez Molina
José Luis Sarasa Corral
Juan Antonio Rey Herranz
Publication date
01-01-2004
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 1/2004
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710300

Other articles of this Issue 1/2004

Clinical and Translational Oncology 1/2004 Go to the issue

Editorial

Translational research in Radio-Oncology: how to integrate it into clinical orthodoxy?

Notas Clínicas

Hamartoma mamario: un tumor infrecuente

Originales

Experiencia clínica con reservorios venosos subcutáneoos en pacientes oncológicos

Sección Docente

Chemotherapy in resectable non-small cell lung cancer

Revisiones

ErbB tyrosine kinase receptor inhibitors in breast cancer treatment

Announcement

Información
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits